Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 3
2012 3
2013 3
2014 4
2015 4
2016 1
2017 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture.
Zhang Q, Sidorenko J, Couvy-Duchesne B, Marioni RE, Wright MJ, Goate AM, Marcora E, Huang KL, Porter T, Laws SM; Australian Imaging Biomarkers and Lifestyle (AIBL) Study; Sachdev PS, Mather KA, Armstrong NJ, Thalamuthu A, Brodaty H, Yengo L, Yang J, Wray NR, McRae AF, Visscher PM. Zhang Q, et al. Nat Commun. 2020 Sep 23;11(1):4799. doi: 10.1038/s41467-020-18534-1. Nat Commun. 2020. PMID: 32968074 Free PMC article.
Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer's disease.
Roe JM, Vidal-Piñeiro D, Sørensen Ø, Brandmaier AM, Düzel S, Gonzalez HA, Kievit RA, Knights E, Kühn S, Lindenberger U, Mowinckel AM, Nyberg L, Park DC, Pudas S, Rundle MM, Walhovd KB, Fjell AM, Westerhausen R; Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing. Roe JM, et al. Nat Commun. 2021 Feb 1;12(1):721. doi: 10.1038/s41467-021-21057-y. Nat Commun. 2021. PMID: 33526780 Free PMC article.
Author Correction: Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer's disease.
Roe JM, Vidal-Piñeiro D, Sørensen Ø, Brandmaier AM, Düzel S, Gonzalez HA, Kievit RA, Knights E, Kühn S, Lindenberger U, Mowinckel AM, Nyberg L, Park DC, Pudas S, Rundle MM, Walhovd KB, Fjell AM, Westerhausen R; Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing. Roe JM, et al. Nat Commun. 2022 Feb 7;13(1):834. doi: 10.1038/s41467-022-28514-2. Nat Commun. 2022. PMID: 35132105 Free PMC article. No abstract available.
In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.
Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, Yates P, Piguet O, Pejoska S, Doré V, Yanai K, Masters CL, Kudo Y, Rowe CC, Okamura N. Villemagne VL, et al. Among authors: pejoska s. Eur J Nucl Med Mol Imaging. 2014 May;41(5):816-26. doi: 10.1007/s00259-013-2681-7. Epub 2014 Feb 11. Eur J Nucl Med Mol Imaging. 2014. PMID: 24514874
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Li QX, Villemagne VL, Doecke JD, Rembach A, Sarros S, Varghese S, McGlade A, Laughton KM, Pertile KK, Fowler CJ, Rumble RL, Trounson BO, Taddei K, Rainey-Smith SR, Laws SM, Robertson JS, Evered LA, Silbert B, Ellis KA, Rowe CC, Macaulay SL, Darby D, Martins RN, Ames D, Masters CL, Collins S; AIBL Research Group. Li QX, et al. J Alzheimers Dis. 2015;48(1):175-87. doi: 10.3233/JAD-150247. J Alzheimers Dis. 2015. PMID: 26401938
Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease.
Villemagne VL, Mulligan RS, Pejoska S, Ong K, Jones G, O'Keefe G, Chan JG, Young K, Tochon-Danguy H, Masters CL, Rowe CC. Villemagne VL, et al. Among authors: pejoska s. Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):983-9. doi: 10.1007/s00259-012-2088-x. Epub 2012 Mar 8. Eur J Nucl Med Mol Imaging. 2012. PMID: 22398958 Clinical Trial.
A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.
Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, Salvado O, Macaulay SL, Masters CL, Villemagne VL; Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging, Biomarkers and Lifestyle Study Research Group. Burnham SC, et al. Mol Psychiatry. 2014 Apr;19(4):519-26. doi: 10.1038/mp.2013.40. Epub 2013 Apr 30. Mol Psychiatry. 2014. PMID: 23628985
23 results